Summary
B&C Biopharm (B&C) is a biopharmaceutical venture company. The company discovers and develops pharmaceutical products for the treatment of the infectious diseases. B&C’s product portfolio includes NS5B inhibitors, BC2125, BC2329, NS3 inhibitors, PPI inhibitors, and antifungal agents. The company conducts research to develop therapeutics for Hepatitis C, NS5B RNA polymerase, and NS3 helicase, among others. Its Korean’s patents for drug discoveries are 446669, 516434, and 516433 among oth
Read More
- List of Tables
- B&C Biopharm, Pharmaceuticals & Healthcare, Key Facts 1
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 1
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 1
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 1
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
- B&C Biopharm, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
- B&C Biopharm, Pharmace
Read More
- Table of Contents
- Table of Contents 2
- List of Tables 3
- List of Figures 3
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
- B&C Biopharm, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
- B&C Biopharm, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 8
- B&C Biopharm, Phar
Read More